As the number of COVID-19 infections continues to climb and highly contagious variants of the virus have emerged, some countries are imposing new travel restrictions.
France is prohibiting all travel to and from non-European Union countries. Under the new policy beginning Sunday, travelers from EU countries seeking entry into France will have to provide evidence of a negative coronavirus test.
Travelers from several European and African nations — Brazil, Britian, Eswatini, Ireland, Lesotho, Portugal, and South Africa – will not be allowed into Germany. However, German residents traveling from those countries will be granted entry, even if they test positive for the coronavirus virus.
Fourteen University of Michigan students are in quarantine after being diagnosed with the British variant of the virus. One of the students is reported to have traveled to Britain over the winter break.
Health officials in South Carolina say they have detected two cases of the South African COVID-19 variant, the first cases in the United States.
Johnson & Johnson One-dose Vaccine 66% Successful
US pharmaceutical maker calls vaccine 85% effective in preventing serious illness
U.S. pharmaceutical and medical device maker Johnson & Johnson says after a global trial, the COVID-19 vaccine it has developed is 66% effective in preventing infection.
The one-dose vaccine, which was developed by the company’s Belgian subsidiary, Janssen, appears to be 85% effective in preventing serious illness, even against the South African variant.
Of the 44,000 people who participated in the trial in the U.S., South Africa and Brazil, no one who was given the vaccine died, the company said.
The U.S. has agreed to buy 100 million doses of the vaccine with an option to buy 200 million more, according to the company.
The Johnson & Johnson vaccine is the fourth vaccine approved to fight the pandemic.
Johns Hopkins Coronavirus Resource Center said early Saturday that there are more than 102 million global COVID-19 cases.
The U.S. remains the location with the most cases at 25.9 million, followed by India with 10.7 million and Brazil with 9.1 million.